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Is the information currently available to adjust nutritional recommendations and develop
individualized nutrition? No. There is not even the information needed for setting dietary
recommendations with confidence now at the group level. Will it be available soon? The
answer to this question depends on the drive and will of the nutritional community, the success
in recruiting funding to the area, the education of nutritionists and the spawning of great ideas
and approaches. The emerging tools of genomics, proteomics and metabolomics are enabling
the in-depth study of relationships between diet, genetics and metabolism. The advent of
technologies can be compared with the discovery of the microscope and the new dimensions
of scientific visualization enabled by that discovery. Nutritionists stand at the crest of new
waves of data that can be generated, and new methods for their digestion will be required.
To date, the study of dietary requirements has been based largely on a black box approach.
Subjects are supplemented or depleted and clinical outcomes are observed. Few recommen-
dations are based on metabolic outcomes. Metabolomics and nutrigenomics promise tools with
which recommendations can be refined to meet individual requirements and the potential of
individualized nutrition can be explored. As yet, these tools are not being widely applied in
nutritional research and are rarely being applied by nutritionists. The result is often interest-
ing research that is frequently nutritionally flawed, resulting in inappropriate conclusions.
Nutritional education is needed to put nutritionists at the forefront of the development of
applications for these technologies, creating a generation of nutrigenomicists. A new generation
of nutritionists should be working interdisciplinarily with geneticists, molecular biologists
and bioinformaticians in the development of research strategies. The present paper reviews
the current status of nutrigenomic research, the current controversies and limitations, and
developments needed to advance nutrigenomics and explore fully the promise of individualized
nutritional recommendations.
Dietary recommendations: Metabolomics: Nutrigenomics: Individualized nutrition
A view of the future
The dream of improving individual health through tailored
nutritional recommendations has been well described in
the New York Times in May 2003: ‘A trip to the diet doc,
circa 2013. You prick your finger, draw a little blood and
send it, along with a $100 fee, to a consumer genomics lab
in California. There, it’s passed through a mass spectro-
meter, where its proteins are analyzed. It is cross-
referenced with your DNA profile. A few days later, you
get an email message with your recommended diet for
the next four weeks. It doesn’t look too bad: lots of
salmon, spinach, selenium supplements, bread with olive
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oil. Unsure of just how lucky you ought to feel, you call up
a few friends to see what their diets look like. There are
plenty of quirks. A Greek co-worker is getting clams, crab,
liver and tofu – a bounty of B vitamins to raise her co-
enzyme levels. A friend in Chicago, a second-generation
Zambian, has been prescribed popcorn, kale, peaches in
their own juice and club soda. (This looks a lot like the
hypertension-reducing ‘Dash’ diet, which doesn’t work for
everyone but apparently works for him.) He is allowed
some chicken, prepared in a saltless marinade, hold the
open flame – and he gets extra vitamin D because there’s
not enough sunshine for him at his latitude. (His brother’s
diet, interesting enough, is a fair bit different.) Your boss,
who seems to have won some sort of genetic lottery, gets
to eat plenty of peanut butter, red meat and boutique
cheeses . . .
Nobody is eating exactly what you are. Your diet is
uniquely tailored. It is determined by the specific demands
of your genetic signature, and it perfectly balances your
micronutrient and macronutrient needs. Sick days become
a foggy memory. (Foggy memory itself is now treated with
extracts of ginkgo biloba and a cocktail of omega-3 fatty
acids.) . . . Your cholesterol does not react much to diet so
you can eat bacon sandwiches and don’t need to spend
money on vitamin supplements that aren’t doing anything
for you . . . You willingly take only the vitamins you need
in precisely the right doses, which will postpone the onset
of disease to which you are naturally susceptible’
(Grierson, 2003; reproduced with permission). This posi-
tion is the promise of nutritional genomics.
How is individualized nutrition obtained and why
the sudden expectations about this? The publication of
the human genome heralded a new era of understanding
of how genetic profiles influence disease risk. The human
genome project has provided extensive information on
genes of man, along with those of other species. It has
been humbling to recognize how little unique genetic
material man has compared with other living beings and
the new knowledge that there are only about 30 000 genes;
much fewer than anticipated (Pennisi, 2003). The rapid
success of the sequencing of the genome also demonstrated
the limitations of knowing genes without knowing func-
tion. Thus, genomics, the study of the entire genome,
moved towards transcriptomics (see Mathers, 2004), the
study of mRNA in order to understand which genes are
being transcribed. This approach presented new challenges.
DNA sampling, with the use of either blood or buccal cell
swabs had become very easy. The collection of mRNA,
however, is much more challenging, especially in human
studies. Furthermore, transcription of genes still does not
ensure the activity of their product. The examination of
proteins comes a step closer to the activity of the gene. The
field of proteomics was born and buoyed by the tech-
nologies (described later) that developed, which allowed
measurement of all the proteins in an organism.
Nutrinomics includes genomic, proteomic, transcrip-
tomic, metabolomic and metabonomic measurements (see
Mathers, 2004). Its promise lies in the study and under-
standing of how genetic polymorphisms affect require-
ments, how nutrition influences genetic expression and
subsequently impacts metabolic pathways, and how
regulation is disturbed in diet-related disease (Mueller &
Kerston, 2003).
The emerging tools of genomics, proteomics and
metabolomics are enabling the study of the relationships
between diet, genetics and metabolism in entirely different
depth. These technologies can be compared with the
discovery of the microscope and the new, somewhat over-
whelming, dimensions of scientific visualization that
opened. It has created a need for bioinformaticians to deci-
pher new signals. Nutritionists stand at the crest of new
waves of data that can be generated rapidly with high-
throughput technologies and that require new methods
for their digestion.
Given the current status, there is scepticism about
moving forward and whether public health can be
improved with such tailored recommendations even if the
data are gathered and processed. The high costs of indi-
vidualized assessment and the low level of motivation
by individuals to adhere to a tailored diet are the reasons
for the question of whether this approach will become the
luxury of an elite few who can afford testing and have the
education and the will to become intensely involved in
their health maintenance in the long term. Alternatively,
will nutritional science find its power to prevent disease
enhanced tremendously by knowing genetic profiles and
using the tools spun off by the genomic revolution?
Nutrigenetics v. nutrigenomics
Nutrigenetics addresses the importance of genotype on
the risk of nutritionally-related disease. It starts from the
assumption that certain genetic polymorphisms measurably
alter nutritional deficiency. In nutrigenetics genetic poly-
morphisms are identified and studied to see if they modu-
late the relationships between nutritional exposure and risk.
The inverse relationship is addressed by nutrigenomics,
which focuses on the effect of nutrition or food-borne
components on gene transcription, proteomics and metab-
olism. The premise in this case is that diet influences
disease through mechanisms regulating genetic expression.
Nutrigenomics is more difficult to utilize in nutritional
research than nutrigenetics. It challenges human nutritional
research to carefully design studies that control superfluous
influences, to gather samples that are reflective of the
target tissue, to do so on a critically-important timeline of
responsiveness to the nutritional impact, to conduct highly-
sensitive measurements with internal and external validity
and reproducibly, to be able to handle and interpret
tremendous amounts of data generated from single samples
at single time points in single individuals and to combine
those results to determine patterns that are interpretable.
This approach is a systems biological approach (i.e. the
study of the complete biological system of a tissue, cell or
organism, using the complement of tools from genomics
to metabolomics) that attempts to integrate the measures
across the multiple ‘omics’ for genes, proteins and metab-
olites to allow understanding and robust conclusions.
Nutrigenetics addresses the questions of gene–mutant
interactions relating to whether polymorphisms matter,
whether there is compensation for alterations of single
genes in a pathway or compensation in the expression of
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other genes. A major concern here, as with biomarker-
based studies, is how it can be ensured that the gene under
study is the pivotal one and not just linked to the causal
gene.
Nutrigenetics and recommended intakes
Nutrigenetics may lead to the identification of individuals
who are less efficient in specific metabolic pathways and
to the recommendation of greater intakes. The evidence
of gene–nutrient interactions was first identified with
monogenetic inborn errors of metabolism such as phenyl-
ketonuria, which is a model of the ability to turn such
knowledge into prevention of disease. In phenylketonuria,
to prevent mental retardation, infants are screened at birth
and, where necessary, dietary exposure to phenylalanine
is restricted (National Institutes of Health Consensus
Development Panel, 2001). Subtler effects of dietary needs
of individuals have been discussed at length elsewhere.
They include the understanding of the relationship between
various apoE genotypes 2/2, 2/3 and 4/2 to dietary
responsiveness to the fat in the diet, the relationships
between folic acid needs and polymorphisms of methylene-
tetrahydrofolate reductase and data suggesting that salt
sensitivity is genospecific, and in the aetiology of car-
cinogenesis genotypes of glutathione S-transferase, and
N-acetyltransferase may modulate diet-related cancer risk
(for example, see Frosst et al. 1995; Campos et al. 2002).
Currently-recommended intakes are intended to cover
the needs of 95% of healthy populations, and the neglected
5%, as well as others with health conditions. Subgroups
with greater needs may be identifiable and addressed
directly through nutrigenetics. An example of where the
data are currently accumulating in a way that might justify
polymorphism-based recommendations is in individuals
with specific mutations of the methylenetetrahydrofolate
reductase gene who appear to have a greater need for folic
acid. Nutrigenetics could identify homozygotes and
heterozygotes at risk of undernutrition and ensure that all
individuals receive the greater intake (Cortese & Motti,
2001).
Nutrigenomics
Nutrigenomics is that area of science that employs the
high-throughput technologies developed for genomic
research to assess the entire set of responses to dietary
exposures at the time the sample was taken. Nutrients are
dietary signals that influence gene and protein expression
and metabolic production, working as ‘dietary signatures’
(Mueller & Kersten, 2003). Nutrients such as Se can
influence gene expression directly through transcription
factors, such as nuclear hormone receptors (see Table 1).
These receptors bind retinoic acid, fatty acids, vitamin D
and other fat-soluble food components. In vitro research
has led to understanding the effect of many nutrients on
transcription factors and this knowledge base is expected
to grow. Nutrigenomics also includes proteomic and
metabolomic responses as measurable indicators of dietary
effect. To date, nutritional research stems largely from
transgenic and knock-out mouse models, and in vitro
experiments using inducible expression systems, trans-
dominant negative adenoviral constructs and RNA inter-
ference (Mueller & Kersten, 2003).
The challenge will be to develop useful ways of
incorporating metabonomics into in vivo human research.
Human metabolic profiles change from hour to hour and
from day to day, and are influenced by factors other than
diet, including lifestyle (physical activity, cigarette smok-
ing, environmental exposures and medication use). Deter-
mining the relationship between mRNA and protein levels
depends totally on when they are measured. As illustrated
in Fig. 1, the ratio of the two variables changes radically
at each of the three given time points, as the transcription
ends and the protein synthesis continues to rise. Strategies
for responding to this disparity include multiple measures
at various time points, choosing the peaks for each variable
or integrating measures over time and calculating the area
under the curve.
Apparent major obstacles to the use of metabolomics in
human research are access to the right tissue, measurement
of metabolites at the right time, measurement variability
within individuals and between runs and laboratories.
Another issue is that the same metabolic profile may be
good for some diseases and bad for others. There is a
Table 1. Examples of modulation of gene expression by selenium
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Fig. 1. Time cause and relationship between levels of transcription
and protein expression.
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danger of misinterpreting metabolic data; the butyrate
paradox is one of the examples, in that butyrate shows
cell stimulation in normal colonic epithelium but induces
apoptosis in transformed cells (National Cancer Institute,
2003).
There are a number of issues critical to the experimental
designs that apply these methods. Dietary effects are often
weak, and chronic exposure may be most important;
therefore, short-term feeding studies may not suffice and,
for some effects, hypothetical long-term studies will be
necessary. Also, as food intake is complex, studying the
effect of single substances in isolation may be misleading.
Many nutritionally-related diseases are associated with
multiple genes, and as yet their multidimensional interac-
tions cannot be measured.
At present, these tools are not being widely applied in
nutritional research and are rarely applied by nutritionists.
The result of this situation is interesting, often nutritionally
-flawed research that may result in inappropriate conclu-
sions. The May 2002 National Cancer Institute-sponsored
meeting on nutritional genomics and proteomics in cancer
prevention highlighted numerous experiments on knock-
out mice and responses to specific nutrients in tissue
culture, but showcased few human studies. The need
for interdisciplinary teaching and research has become
evident.
Proteomics
Proteomics is an exciting research front, and valuable
breakthroughs are being made in the area of diagnostics
and therapeutics. These breakthroughs include two-dimen-
sional gel differential display, high-resolution MS, such
as the QSTAR, which can yield 900 000 data points per
sample (as compared with previous levels of 15 000 points)
and protein microarrays, including reverse-phase protein
arrays along with surface-enhanced laser–adsorption ioniza-
tion chip processes in combination with MS. Intelligence-
based bioinformatic tools that involve supervised and
unsupervised learning systems to develop algorithms and
to obtain a proteomic signature are essential to the app-
lication of these methods. Challenges in the general
application of protein microarrays for proteomic research
include the complication of measuring proteins in the same
medium, with log orders of magnitude between the most-
abundant and least-abundant proteins. Another challenge
derives from the fact that proteins cannot be amplified and,
therefore, must be tagged in some way.
The best examples of proteomic advances to date are
new proteomic-based diagnostic approaches to the identi-
fication of difficult diseases, such as early-stage ovarian
cancer. Based on the concept that perfusion of cancerous
tissues will result in abnormal protein profiles in the blood,
and that the identification of the specific proteins is not
necessary as long as patterns are recognizable, proteomic
spectra (generated by MS, using surface-enhanced laser
desorption and ionization) of serum of women with and
without ovarian cancer have provided information for
learning algorithms that have successfully discriminated
between diseased and non-diseased women with 100%
sensitivity and 100% specificity (Petricoin et al. 2002).
Two major issues thwart the use of proteomics in a
nutritional context. One is the importance of the site of the
protein in the interpretation of the importance of protein
differences. Direct measurement of adrenal, or liver,
or target tissue proteins is desirable for many lines of
research, but is clearly not feasible for human subjects.
In addition, protein chemistry is extraordinarily difficult
and high-throughput approaches for studying multiple
proteins are limited. As blood and urine are easily
accessible as possible media, and the technology is avail-
able for studying small-molecular-weight substances,
metabonomics has become the champion of the ‘-omics’.
Metabonomics is the study of the entire set of metabolites
(small-molecular-weight substances) of an organism, as
contrasted with metabolomics, the study of the set of
metabolites in a tissue or organ.
Current requirements
The study of dietary requirements has been based largely
on black box measures; outcomes of clinical relevance,
rather than metabolic end points. Typically, subjects are
experimentally supplemented or depleted and monitored
to see what happens. Clinical outcomes at various levels
of intake of a diet that is complete in all other nutrients
except the one under study are monitored for the levels
that trigger measurable or visible responses. When infor-
mation of this nature is lacking, which is often for many
outcomes, or is available but only in subpopulations that
are not reflective of the population at large, recommenda-
tions are founded on information on intakes in seemingly
healthy populations, as is the case with adequate intake
levels as defined by the National Academy of Sciences. In
the case of upper tolerable limits, most recommendations
are based on animal experiments and adjusted with safety
factors (Institute of Medicine Food and Nutrition Board,
2000). To individualize nutritional recommendations will
increase the complexity and require similar information
on subgroups with different genetic profiles and the infor-
mation on the effects of combinations of polymorphisms
with different diets on multiple outcomes.
This information is available for very few nutrients and
only in relation to single genes. The information needed
to individualize recommendations is largely unavailable
for most nutrients. In fact, anyone who has been involved
in the development of dietary recommendations, such as
the dietary reference intakes of the National Academy of
Sciences in the USA, can attest to the fact that the data for
setting exact recommendations for intakes of groups are
severely limited. This situation applies to estimates of
the levels needed to keep half a population adequately
nourished (estimated average requirement), as well as the
levels that are safe (upper tolerable limits) for most of the
population most of the time.
It would, however, be wrong to assume that there is
currently no individualization of requirements; re-
commended intakes differ depending on physiological
state (age, pregnancy, lactation) and genetics (gender).
Most recently, they are also adjusted for lifestyle (cigarette
smoking and vitamin C). However, going beyond this
position suggests that other genetic factors will play a part
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in recommendations and at least one, probably dozens,
of genetic polymorphism states of multiple genes in each
individual and their physiological responses will be
involved in future generations of recommendations. It
remains doubtful that recommendations will be based on
metabolomics alone.
Few dietary recommendations are based on metabolic
markers for a number of reasons, ranging from the lack
of confidence in these factors as outcome markers, their
unproven linkage to the health outcome of interest and
their variability both within and between individuals.
The extensive information available, for example, from
the superb studies conducted at the National Institutes of
Health on ascorbic acid defines clearly the intake levels
associated with leucocyte saturation (Levine et al. 1996).
However, the National Academy of Sciences committee
involved in developing the estimated average requirement
for ascorbic acid did not find saturation a strong enough
outcome to be the basis for recommended intakes for
vitamin C (Institute of Medicine Food and Nutrition
Board, 2000). Thus, the use of metabolomic outcomes
as a primary basis for determining individual recommenda-
tions is of questionable utility. The need to couple these
measures with outcome data will remain.
What do nutritionists need to learn?
The next generation of nutritionists will need enough
genetics to understand terminology, enough metabolism
to understand the pathways, enough molecular biology to
understand how nutrients work at the cellular level, enough
statistics to appreciate informatic challenges and to under-
stand the strategies, and enough laboratory experience to
appreciate measurement error in the methods used. They
will require enough epidemiology to design studies in
appropriate populations with adequate power and robust
measures, where the noise does not dominate over any
signals coming from the data, and to ensure internal and
external generalizability of studies. They will need to know
the pathways of interest, all the genes that might be in-
volved, the compensatory mechanisms in place and the
frequencies of alleles.
A set of growing resources on genes and metabolic
pathways, such as those listed in Table 2, provides support.
These resources include websites such as the Human
Genic Bi-Allelic Sequences database (see Table 2), which
provides sequence variations and their physical relation-
ship to the gene for over 22 000 single nucleotide poly-
morphisms, the Genbank accession number, location of
polymorphism and population allele frequencies. The
Kyoto Encyclopedia of Genes and Genomes for Pathways
is another resource of the Genome Net (see Table 2) for
understanding cellular function from genome information.
This resource integrates information about genes and
proteins with molecular pathways in the cell.
Nutritional education needs to evolve to put nutritionists
at the forefront of the development of applications for these
technologies, creating a generation of nutrigenomicists
capable of working interdisciplinarily with geneticists,
molecular biologists and bioinformaticians.
Conclusions
The Human Genome Project and its offspring have
provided enormous resources and tools that promise to
enhance the depth of understanding about gene–nutrient
interactions.
The risk of human disease has long been recognized to
be the result of interaction between genetic susceptibility
and environmental risk factors, in the longstanding nature
v. nurture arguments. Now the ability to quantify effects
and examine pathways in exquisite detail is becoming
possible. In order to utilize this potential, education of
nutritional professionals who can direct the research to
areas relevant to public health is needed and possibly new
subspecialities developed.
It is my hope that for this area of nutritional research
there will be hypothesis-driven research on nutritional
pathways in the study of the genetic input and effects
of diet or environment on the metabolic cascade. This
research should address the differences between indi-
viduals under controlled conditions and the effects within
individuals as diet changes. The study of specific gene and
specific metabolite changes in well-controlled feeding
studies will help to isolate relevant dietary factors and
vulnerable populations.
Nutrigenetic research presents a number of challenges.
The pursuit of nutrigenetics requires relatively frequent
genes to allow the detection of effect in the populations
studied, a relatively strong effect, the fortune or design to
study the effective dose and consideration of the poly-
genetic nature of most nutritionally-related diseases. For
the epidemiologist the challenge is to identify the genes
that may be of central importance, identify whether they
are causal or just correlated through linkage disequilibria,
measure them and design studies with enough power to
test clearly whether the genotype impacts disease risk. To
meet this challenge, the level of nutrient at which an effect
is evident needs to be known. According to experience to
date in gene–nutrient interactions, the relationship suggests
less of a dose–response effect than that of a plateau effect.
The greatest differences appear to be among deficiencies
not among individuals at the higher intakes. Most of the
interaction that takes place is in the low dietary exposures,
as is the case with methylenetetrahydrofolate reductase
and folic acid requirements.
Table 2. A sampling of website resources to identify genes
Human Genic Bi-Allelic Sequences http://hgbase.interactiva.de/
Genome Net http://www.genome.ad.jp/kegg/kegg2.html
Environmental Genome Project http://egp.gs.washington.edu/
National Center for Biotechnology Information
http://www.ncbi.nlm.nih.gov/
Human Gene Mutation Database at the Institute of Medical Genetics
in Cardiff http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html
National Center for Biotechnology Information
http://www.ncbi.nlm.nih.gov/Omim/
The Cancer Genome Anatomy Project http://cgap.nci.nih.gov/
The SNP Consortium Ltd http://snp.cshl.org/
UNC–CH Center for Bioinformatics
http://bioinformatics.unc.edu/bioinformatics
Genetic influences on dietary requirements 171
https://www.cambridge.org/core/terms. https://doi.org/10.1079/PNS2003325
Downloaded from https://www.cambridge.org/core. IP address: 136.56.14.111, on 05 Feb 2021 at 19:57:31, subject to the Cambridge Core terms of use, available at
The flaw with the image of the future drawn by Grierson
(2003) in the introduction to the present paper is that it
suggests that alterations of diet in adulthood may not
affect the risk of chronic diseases. In fact, the more
realistic follow-through of this scenario would be parents
testing their infants at birth for their nutrigenetic profiles,
and determining at that time the most ideal diet (according
to current opinion) for the child in order to intervene
before the fetal origins of disease can develop into the
later decade realities and so that dietary damage cannot
accumulate. It will require confidence that the proposed
dietary recommendations and avoidances do not interfere
with health in other ways, from fertility to asthma, from
brain development to infectious disease risk and perfor-
mance in other areas. The impact of individual foods and
nutrients on all relevant time periods in development is
not yet understood. However, concerted research in this
area will present opportunities for nutritional scientists to
refine recommendations.
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